Application 209696
- Type
- ANDA
- Sponsor
- INVENTIA HLTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | TABLET;ORAL | 5MG | No | No |
| 002 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | TABLET;ORAL | 7.5MG | No | No |
| 003 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | TABLET;ORAL | 10MG | No | No |
| 004 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | TABLET;ORAL | 15MG | No | No |
| 005 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | TABLET;ORAL | 30MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209696-001 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 5MG | TABLET / ORAL | BX | 2018-05-03 | |
| A209696-002 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 7.5MG | TABLET / ORAL | BX | 2018-05-03 | |
| A209696-003 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 10MG | TABLET / ORAL | BX | 2018-05-03 | |
| A209696-004 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 15MG | TABLET / ORAL | BX | 2018-05-03 | |
| A209696-005 | BUSPIRONE HYDROCHLORIDE | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET / ORAL | BX | 2018-05-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A209696-001 | BX |
| A209696-002 | BX |
| A209696-003 | BX |
| A209696-004 | BX |
| A209696-005 | BX |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A209696-001 | BUSPIRONE HYDROCHLORIDE | 5MG | TABLET / ORAL | BX | 2018-05-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209696-002 | BUSPIRONE HYDROCHLORIDE | 7.5MG | TABLET / ORAL | BX | 2018-05-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209696-003 | BUSPIRONE HYDROCHLORIDE | 10MG | TABLET / ORAL | BX | 2018-05-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209696-004 | BUSPIRONE HYDROCHLORIDE | 15MG | TABLET / ORAL | BX | 2018-05-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A209696-005 | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET / ORAL | BX | 2018-05-03 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209696-001 | BUSPIRONE HYDROCHLORIDE | 5MG | TABLET / ORAL | BX | 2018-05-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209696-002 | BUSPIRONE HYDROCHLORIDE | 7.5MG | TABLET / ORAL | BX | 2018-05-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209696-003 | BUSPIRONE HYDROCHLORIDE | 10MG | TABLET / ORAL | BX | 2018-05-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209696-004 | BUSPIRONE HYDROCHLORIDE | 15MG | TABLET / ORAL | BX | 2018-05-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209696-005 | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET / ORAL | BX | 2018-05-03 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209696-001 | BUSPIRONE HYDROCHLORIDE | 5MG | TABLET / ORAL | BX | 2018-05-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209696-002 | BUSPIRONE HYDROCHLORIDE | 7.5MG | TABLET / ORAL | BX | 2018-05-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209696-003 | BUSPIRONE HYDROCHLORIDE | 10MG | TABLET / ORAL | BX | 2018-05-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209696-004 | BUSPIRONE HYDROCHLORIDE | 15MG | TABLET / ORAL | BX | 2018-05-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A209696-005 | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET / ORAL | BX | 2018-05-03 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209696-001 | BUSPIRONE HYDROCHLORIDE | 5MG | TABLET / ORAL | AB | 2018-05-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209696-002 | BUSPIRONE HYDROCHLORIDE | 7.5MG | TABLET / ORAL | AB | 2018-05-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209696-003 | BUSPIRONE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 2018-05-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209696-004 | BUSPIRONE HYDROCHLORIDE | 15MG | TABLET / ORAL | AB | 2018-05-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209696-005 | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET / ORAL | AB | 2018-05-03 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209696-001 | BUSPIRONE HYDROCHLORIDE | 5MG | TABLET / ORAL | AB | 2018-05-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209696-002 | BUSPIRONE HYDROCHLORIDE | 7.5MG | TABLET / ORAL | AB | 2018-05-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209696-003 | BUSPIRONE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 2018-05-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209696-004 | BUSPIRONE HYDROCHLORIDE | 15MG | TABLET / ORAL | AB | 2018-05-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209696-005 | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET / ORAL | AB | 2018-05-03 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209696-001 | BUSPIRONE HYDROCHLORIDE | 5MG | TABLET / ORAL | AB | 2018-05-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209696-002 | BUSPIRONE HYDROCHLORIDE | 7.5MG | TABLET / ORAL | AB | 2018-05-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209696-003 | BUSPIRONE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 2018-05-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209696-004 | BUSPIRONE HYDROCHLORIDE | 15MG | TABLET / ORAL | AB | 2018-05-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209696-005 | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET / ORAL | AB | 2018-05-03 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209696-001 | BUSPIRONE HYDROCHLORIDE | 5MG | TABLET / ORAL | AB | 2018-05-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209696-002 | BUSPIRONE HYDROCHLORIDE | 7.5MG | TABLET / ORAL | AB | 2018-05-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209696-003 | BUSPIRONE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 2018-05-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209696-004 | BUSPIRONE HYDROCHLORIDE | 15MG | TABLET / ORAL | AB | 2018-05-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209696-005 | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET / ORAL | AB | 2018-05-03 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209696-001 | BUSPIRONE HYDROCHLORIDE | 5MG | TABLET / ORAL | AB | 2018-05-03 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209696-002 | BUSPIRONE HYDROCHLORIDE | 7.5MG | TABLET / ORAL | AB | 2018-05-03 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209696-003 | BUSPIRONE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 2018-05-03 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209696-004 | BUSPIRONE HYDROCHLORIDE | 15MG | TABLET / ORAL | AB | 2018-05-03 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209696-005 | BUSPIRONE HYDROCHLORIDE | 30MG | TABLET / ORAL | AB | 2018-05-03 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A209696-001 | BX | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209696-002 | BX | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209696-003 | BX | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209696-004 | BX | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A209696-005 | BX | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209696-001 | BX | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209696-002 | BX | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209696-003 | BX | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209696-004 | BX | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A209696-005 | BX | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A209696-001 | BX | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209696-002 | BX | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209696-003 | BX | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209696-004 | BX | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A209696-005 | BX | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209696-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209696-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209696-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209696-004 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A209696-005 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209696-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209696-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209696-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209696-004 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A209696-005 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209696-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209696-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209696-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209696-004 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A209696-005 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209696-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209696-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209696-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209696-004 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A209696-005 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209696-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209696-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209696-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209696-004 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A209696-005 | AB | 1 | 5bbf6a4d5a75… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Bryant Ranch Prepack | 267d8897-90dd-4f8a-bbd8-8aa4e47c2905 | 2024-07-09 | Warnings, Adverse reactions | 209696 ANDA209696 71335-1144 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | APNAR PHARMA LP | 3c115eea-9dbc-4e2c-9d79-42e3388fde5a | 2024-06-17 | Warnings, Adverse reactions | 209696 ANDA209696 24689-785 24689-921 24689-933 24689-907 24689-781 |
| Buspirone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Nivagen Pharmaceuticals Inc. | b08dd2e7-e808-4b51-b404-5009076b82eb | 2021-02-25 | Warnings, Adverse reactions | 209696 ANDA209696 75834-269 75834-268 75834-267 75834-266 75834-270 |
| BusPIRone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Proficient Rx LP | 03efd618-8ca3-43d0-bbeb-55e53b5308e8 | 2020-04-01 | Warnings, Adverse reactions | 209696 ANDA209696 71205-280 |
| BusPIRone Hydrochloride | BUSPIRONE HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | e2c672b3-6130-4dd1-8066-0ce9451cb8c7 | 2019-06-06 | Warnings, Adverse reactions | 209696 ANDA209696 71610-291 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 24689-781 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | APNAR PHARMA LP | ANDA | Current |
| 24689-781 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | APNAR PHARMA LP | ANDA | Current |
| 24689-785 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | APNAR PHARMA LP | ANDA | Current |
| 24689-785 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | APNAR PHARMA LP | ANDA | Current |
| 24689-907 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | APNAR PHARMA LP | ANDA | Current |
| 24689-907 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | APNAR PHARMA LP | ANDA | Current |
| 24689-921 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | APNAR PHARMA LP | ANDA | Current |
| 24689-921 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | APNAR PHARMA LP | ANDA | Current |
| 24689-933 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | APNAR PHARMA LP | ANDA | Current |
| 24689-933 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | APNAR PHARMA LP | ANDA | Current |
| 49252-098 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | Inventia Healthcare Private Limited | ANDA | Current |
| 49252-099 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | Inventia Healthcare Private Limited | ANDA | Current |
| 49252-100 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | Inventia Healthcare Private Limited | ANDA | Current |
| 49252-101 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | Inventia Healthcare Private Limited | ANDA | Current |
| 49252-107 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | Inventia Healthcare Private Limited | ANDA | Current |
| 53002-5017 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | RPK Pharmaceuticals, Inc. | ANDA | Current |
| 71205-280 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | Proficient Rx LP | ANDA | Current |
| 71205-280 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | Proficient Rx LP | ANDA | Current |
| 71335-1144 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | Bryant Ranch Prepack | ANDA | Current |
| 71335-1144 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | Bryant Ranch Prepack | ANDA | Current |
| 71610-281 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 71610-291 | BusPIRone Hydrochloride | BusPIRone Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | ANDA | Current |
| 75834-266 | Buspirone Hydrochloride | Buspirone Hydrochloride | Nivagen Pharmaceuticals Inc. | ANDA | Current |
| 75834-267 | Buspirone Hydrochloride | Buspirone Hydrochloride | Nivagen Pharmaceuticals Inc. | ANDA | Current |
| 75834-268 | Buspirone Hydrochloride | Buspirone Hydrochloride | Nivagen Pharmaceuticals Inc. | ANDA | Current |
| 75834-269 | Buspirone Hydrochloride | Buspirone Hydrochloride | Nivagen Pharmaceuticals Inc. | ANDA | Current |
| 75834-270 | Buspirone Hydrochloride | Buspirone Hydrochloride | Nivagen Pharmaceuticals Inc. | ANDA | Current |